Pomerantz LLP is investigating Oxford Industries, Inc. regarding potential securities fraud and other unlawful business practices following a significant reduction in the company's full-year revenue guidance. The investigation concerns whether Oxford and certain of its officers and/or directors engaged in securities fraud. This scrutiny comes after Oxford Industries cut its FY 2026 revenue guidance midpoint to $1.49 billion from a previously maintained $1.50 billion, projecting Q2 sales roughly 5.8% below consensus estimates. The disclosure caused the stock to drop $7.36 per share, or 17.01%, to close at $35.92 on June 11, 2026.

Oxford Industries published its Q1 FY 2026 results on June 10, 2026, via Form 8-K. While Q1 revenue came in essentially flat year-over-year, the forward outlook drove the selloff. Management projected Q2 FY 2026 sales at approximately $390 million. The full-year FY 2026 revenue guidance midpoint was reduced from $1.50 billion to $1.49 billion. Weeks before the guidance cut became public, Oxford Industries told investors in a January 12, 2026 Form 8-K filed under Regulation FD that performance during the Holiday and Resort selling seasons was "on track to meet the low end of its previously issued guidance."

Executive Stock Sales

Prior to the guidance cut, a cluster of executive dispositions was disclosed in Form 4 filings. On June 2, 2026, CEO Tom Chubb disposed of 4,009 shares at $44.62. On the same date and at the same price, CFO Scott Grassmyer sold 1,529 shares and Tommy Bahama CEO Doug Wood also sold shares. The timing of these sales is under review to determine if officers possessed material information regarding the forthcoming guidance reduction.

Segment Performance

Operational highlights show a mixed performance across brands. Tommy Bahama reported mid-single-digit positive comparable sales, while Lilly Pulitzer and Johnny Was experienced softer results. Gross margin decreased to 62.3% from 64.2%, impacted by tariff costs and a higher LIFO accounting charge.

Outlook and Guidance

For fiscal 2026, the company narrowed its net sales outlook to a range of $1.475 billion to $1.505 billion. GAAP EPS is projected between $1.70 and $2.10, while adjusted EPS is expected to be between $2.30 and $2.70. The reduction in the revenue guidance midpoint is the primary trigger for the stock's decline and the subsequent legal scrutiny.

Investor Information

Pomerantz LLP notes that investors of Oxford Industries are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980, to discuss their rights. The firm operates on a contingency basis with no upfront costs for investors.